LinkedIn Profile

Access Critical Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:criticalpharmaceuticals 99668 Feb 17th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 16th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 15th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 14th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 13th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 12th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 11th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 10th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 9th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology
private:criticalpharmaceuticals 99668 Feb 8th, 2018 12:00AM Critical Pharmaceuticals Ltd. 807 8.00 Open Biotechnology Feb 8th, 2017 11:57AM Feb 8th, 2017 11:57AM Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections. Critical Pharmaceuticals Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.